PRLD Competitors & Alternatives
Compare Prelude Therapeutics Inc with similar stocks in the same industry
Biotechnology
PRLD
Main Stock$4.38
Tradestie Score
58
Market Cap
$85.47M
Revenue Growth
0.4%
Analyst Upside
+82.6%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.02
|
$382.04M | - | 51 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$9.80
|
$371.64M | - | 53 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$29.60
|
$357.51M | - | 56 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.75
|
$354.45M | - | 60 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$30.60
|
$353.70M | - | 58 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.80
|
$350.98M | - | 62 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.91
|
$341.56M | - | 59 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.28
|
$332.96M | - | 53 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.42
|
$328.62M | - | 63 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.08
|
$304.12M | - | 61 | Compare |
More PRLD Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry